Gene editing market value

the equity market capitalization of gene editing and gene therapy companies could grow 54% at a compound annual rate of return, scaling from roughly $130 billion today to $1.1 trillion by 2026.

Source

Verdict

Not graded yet.

All captured fields

idea

Gene Editing

target year

2026

metric

market capitalization of gene editing and gene therapy companies

value

1.1

unit

USD trillion

subject

Gene editing market value

page

77

confidence

high

note

p83: share of total pharma R&D spend on gene editing and therapy companies could grow from 3% to 17% by 2026.